Vanguard Group Inc Nuvation Bio Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,818,747 shares of NUVB stock, worth $28.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,818,747

Previous 10,142,898 6.66%

Holding current value

$28.5 Million

Previous $29.6 Million 15.98%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.3 - $3.83 $1.55 Million - $2.59 Million	675,849 Added 6.66%	10,818,747 $24.9 Million
Q2 2024 Aug 13, 2024	BUY	$2.58 - $3.69 $6.73 Million - $9.63 Million	2,608,750 Added 34.63%	10,142,898 $29.6 Million
Q1 2024 May 10, 2024	BUY	$1.46 - $3.97 $320,518 - $871,546	219,533 Added 3.0%	7,534,148 $27.4 Million
Q4 2023 Feb 14, 2024	BUY	$0.96 - $1.53 $17,718 - $28,239	18,457 Added 0.25%	7,314,615 $11 Million
Q3 2023 Nov 14, 2023	BUY	$1.26 - $2.1 $21,568 - $35,947	17,118 Added 0.24%	7,296,158 $9.78 Million
Q2 2023 Aug 14, 2023	BUY	$1.56 - $1.84 $119,455 - $140,896	76,574 Added 1.06%	7,279,040 $13.1 Million
Q1 2023 May 15, 2023	SELL	$1.6 - $2.48 $4.37 Million - $6.77 Million	-2,729,975 Reduced 27.49%	7,202,466 $12 Million
Q4 2022 Feb 10, 2023	SELL	$1.68 - $2.5 $4.56 Million - $6.78 Million	-2,712,010 Reduced 21.45%	9,932,441 $19.1 Million
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $3,425 - $47,724	11,813 Added 0.09%	12,644,451 $28.3 Million
Q2 2022 Aug 12, 2022	SELL	$3.24 - $5.85 $971,423 - $1.75 Million	-299,822 Reduced 2.32%	12,632,638 $40.9 Million
Q1 2022 May 13, 2022	BUY	$4.6 - $8.83 $7.69 Million - $14.8 Million	1,671,908 Added 14.85%	12,932,460 $68 Million
Q4 2021 Feb 14, 2022	SELL	$7.75 - $10.05 $4.98 Million - $6.45 Million	-641,975 Reduced 5.39%	11,260,552 $95.7 Million
Q3 2021 Nov 12, 2021	BUY	$7.78 - $10.0 $6.27 Million - $8.06 Million	806,166 Added 7.27%	11,902,527 $118 Million
Q2 2021 Aug 13, 2021	BUY	$9.22 - $14.48 $102 Million - $161 Million	11,096,361 New	11,096,361 $103 Million

Others Institutions Holding NUVB

# of Institutions

159

Shares Held

157M

Call Options Held

3.2K

Put Options Held

98.7K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $571M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Nuvation Bio Inc. Transaction History